NeoGenomics
309 hedge funds and large institutions have $4.02B invested in NeoGenomics in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 89 increasing their positions, 109 reducing their positions, and 56 closing their positions.
1.57% more ownership
Funds ownership: 94.15% → 95.72% (+1.6%)
5% less funds holding
Funds holding: 324 → 309 (-15)
18% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 109
25% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 56
28% less capital invested
Capital invested by funds: $5.56B → $4.02B (-$1.55B)
38% less call options, than puts
Call options by funds: $9.05M | Put options by funds: $14.6M
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$136M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$32.8M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$31.4M |
| 4 |
BlackRock
New York
|
+$22.3M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$15.5M |
Top Sellers
NEO Hedge Fund Activity: Q4 2021 in Review
309 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2021, worth a combined $4.02B — down 28% from $5.56B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of NEO and 42 opened new positions — a net loss of 14 holders — while 109 trimmed existing stakes and 89 added.
The largest buyer was Wellington Management Group, adding an estimated $136M. The largest seller was Driehaus Capital Management, cutting an estimated $31.3M.
- 309 institutional investors held NeoGenomics (NEO) as of Q4 2021, down from 324 in Q3 2021.
- Funds reported $4.02B of NeoGenomics stock for Q4 2021, down 28% quarter-over-quarter.
- 42 funds opened new NeoGenomics positions in Q4 2021 and 56 closed out, a net change of -14 holders.
- The largest NeoGenomics buyer in Q4 2021 was Wellington Management Group, an estimated $136M added.
- The largest NeoGenomics seller in Q4 2021 was Driehaus Capital Management, an estimated $31.3M sold.
Based on aggregated 13F filings for Q4 2021.